SLC1A5 and ovarian carcinoma: Ma et al. [119] reported that circ_0025033 affected the mitochondrial glutamine transporter for metabolic reprogramming SLC1A5 in EOC cells [144], via sponging miR-370-3p, resulting in the abolition of its anti-ovarian cancer role.